AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.7500
-0.0700 (-8.54%)
At close: Dec 3, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $12.31 million as of December 5, 2025. Its market cap has increased by 218.27% in one year.
Market Cap
12.31M
Enterprise Value
12.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 12.31M, a decrease of -39.69%. That is a compound annual growth rate of -12.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 12.31M | 142.25% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 531.36M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 364.92M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |